Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rubitecan vs 5-FU in Refractory Pancreatic Cancer
NCT00005871Phase 3Unknown
- Sponsor
- Astex Pharmaceuticals
- Start
- Nov 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rubitecan in pancreatic cancer (PC), sponsored by Astex Pharmaceuticals. Status: unknown.
02
Drugs
rubitecan
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00005871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005871.